Cargando…
Walking the talk in digital transformation of regulatory review
Cloud-based regulatory platforms have the potential to substantially transform how regulatory submissions are developed, transmitted, and reviewed across the full life cycle of drug development. The benefits of cloud-based submission and review include accelerating critical therapies to patients in...
Autores principales: | Khalil, Ramy, Macdonald, Judith C., Gustafson, Andrew, Aljuburi, Lina, Bisordi, Fabio, Beakes-Read, Ginny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411640/ https://www.ncbi.nlm.nih.gov/pubmed/37564043 http://dx.doi.org/10.3389/fmed.2023.1233142 |
Ejemplares similares
-
Medicinal Product Development and Regulatory Agilities Implemented During the Early Phases of the COVID-19 Pandemic: Experiences and Implications for the Future—An Industry View
por: Geraci, Gaia, et al.
Publicado: (2023) -
Talking the talk to walking the talk
por: Dam, Abhijit K
Publicado: (2020) -
Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem—Are We Ready for a Revolution?
por: Macdonald, Judith C., et al.
Publicado: (2021) -
Connected health in US, EU, and China: opportunities to accelerate regulation of connected health technologies to optimize their role in medicines development
por: Awad, Susan, et al.
Publicado: (2023) -
Analysis of FDA's Accelerated Approval Program Performance December 1992–December 2021
por: Beakes-Read, Ginny, et al.
Publicado: (2022)